There are 410 resources available
214P - Development of a nomogram to predict the progression-free survival in lung cancer patients
Presenter: Hassan TAFENZI
Session: Poster Display session
215P - Assessment of patient and clinician awareness and clinical outcomes of changes in lifestyle habits during lung cancer treatment
Presenter: Ana Isabel Martin Quesada
Session: Poster Display session
216P - Differences in immune checkpoint inhibitor (ICI) approvals made by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for thoracic malignancies
Presenter: Numair Rizwan
Session: Poster Display session
217P - Robotic-assisted navigation system for preoperative percutaneous lung nodule localization: A pilot study
Presenter: Yuechun Lin
Session: Poster Display session
218P - Implications of the eighth edition of TNM staging system for thymoma, a single-center retrospective study
Presenter: Iddo Vardi
Session: Poster Display session
219P - Clinical outcomes for advanced thymoma patients receiving platinum-based chemotherapy as first-line treatment
Presenter: Yue Hao
Session: Poster Display session
220P - Comparison of efficacy and safety of platinum-based chemotherapy as first-line therapy between B3 thymoma and thymic carcinoma
Presenter: Yue Hao
Session: Poster Display session
221P - Comparison of efficacy and safety of carboplatin combined with nab-paclitaxel or paclitaxel as first-line therapy for advanced thymic epithelial tumors
Presenter: Yue Hao
Session: Poster Display session
222P - Thoracic neuroendocrine tumors: Experience in a third level hospital in Mexico
Presenter: Rodrigo Riera Sala
Session: Poster Display session
223P - Surgery versus bronchoscopic cryotherapy for the treatment of lung carcinoid tumors: An overview of 5-year experience
Presenter: Fatmir Caushi
Session: Poster Display session